Clinical Trials Logo

Emergencies clinical trials

View clinical trials related to Emergencies.

Filter by:

NCT ID: NCT05325580 Recruiting - Head Pain Clinical Trials

Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department

Start date: December 1, 2021
Phase: Phase 3
Study type: Interventional

Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department

NCT ID: NCT05304442 Recruiting - Clinical trials for Anemia, Iron Deficiency

IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department

Start date: September 15, 2022
Phase: Phase 3
Study type: Interventional

The primary aim of this randomized trial is to assess the efficacy of IV Ferric Derisomaltose vs Oral Iron in the management of women with severe Iron Deficiency Anemia due to Uterine Bleeding in the emergency department.

NCT ID: NCT05294445 Recruiting - Clinical trials for Atrial Fibrillation (AF)

From the Emergency Department Directly to Ablation of Atrial Fibrillation Study

EMERGE Cryo
Start date: December 15, 2021
Phase: N/A
Study type: Interventional

The study is a prospective, two-arm, randomized, open-label, blinded endpoint, multi-center study to investigate the impact of first line ablation in patients presenting at the emergency room with recent-onset paroxysmal or persistent atrial fibrillation.

NCT ID: NCT05285605 Recruiting - Contraception Clinical Trials

Advance Provision of Postpartum Emergency Contraception and Its Effects on Reproductive Autonomy

Start date: March 1, 2022
Phase:
Study type: Observational

This study will entail provision of ulipristal acetate (UPA) for emergency contraception (EC) in the postpartum period for patients who have not chosen to initiate a highly effective form of contraception and study the use of EC overall as well as with regards to participants' perception of reproductive autonomy. The investigators hypothesize that providing an advance supply of EC will increase use and decrease barriers to use. Additionally, the investigators hypothesize that, with thorough EC counseling, participants will develop an increased knowledge base of EC. With increased use and knowledge, the investigators hypothesize that participants will experience greater reproductive autonomy over their contraceptive decisions.

NCT ID: NCT05274607 Recruiting - Pneumonia Clinical Trials

Pneumonia and Empyema in Emergency Departments in Children

Start date: June 1, 2009
Phase:
Study type: Observational [Patient Registry]

Describe the epidemiology of hospitalized pediatric pneumonia and pneumonia with pleural effusion: frequency, clinical and biological characteristics, responsible bacteria and pneumococcus place, antibiotic resistance, treatment, vaccine status.

NCT ID: NCT05251246 Recruiting - Healthy Clinical Trials

Impact of Stress and Sleep Management on Emergency Professionals

REST
Start date: February 8, 2022
Phase: N/A
Study type: Interventional

The investigators hypothesize that a recovery management program could have an impact on emergency nurses and physicians by improving their sleep and reducing their psychological and physiological responses when dealing with stressful situations during their professional practice. The REST study consists in developing a recovery management program for emergency professionals. The following strategies would be proposed : - sleep management according to their schedules by anticipation and recovery, - stress management through cardio-feedback techniques (cardiac coherence) also called controlled breathing techniques and mental imagery. The objectives are to evaluate the impact of this program on the physiological and psychological stress of the emergency professionals during their professional activity, as well as on their sleep. To do so, their respiratory and heart rates, as well as their activity and resting times will be recorded continuously for one week. At the end of each shift, the emergency professionals will report and evaluate the 3 most stressful events.

NCT ID: NCT05237141 Recruiting - Contraception Clinical Trials

Etonogestrel Implant as Emergency Contraception

Start date: April 1, 2022
Phase: Phase 4
Study type: Interventional

The investigators propose a single site, single arm, open label mechanism of action pharmacodynamic pilot study of etonogestrel implant insertion prior to an luteinizing hormone (LH) surge. The investigators will evaluate ovulation rates via serum levels of reproductive hormones and transvaginal ultrasound findings following placement of an etonogestrel implant once the dominant follicle reaches a size of 15mm or greater, but prior to an LH surge, in persons with prior documented regular cycles and confirmed ovulation. The researchers' hypothesis is that ovulation will be inhibited if the etonogestrel implant is placed prior to an LH surge. Based on data from the Food and Drug Administration label for Nexplanon, etonogestrel rises to levels associated with ovulation suppression within 8 hours of placement. Given this rapid increase, it is therefore plausible to assume that ovulation can be inhibited by the implant if placed prior to an LH surge. This study is novel as there have been no published studies evaluating an etonogestrel implant for this indication. The contribution of this proposed research to the literature is significant because current recommendations from the Center for Disease Control (CDC) regarding timing of etonogestrel implant placement are stringent and not patient-centered. Any day insertion of the etonogestrel implant is supported by retrospective data and this pharmacodynamic data would further support the literature for any day insertion without the need for additional emergency contraception. If results support the investigators' hypothesis, it could increase access to contraception and decrease duplicative therapy.

NCT ID: NCT05229055 Recruiting - Acute Pain Clinical Trials

Intranasal Ketamine Versus Subcutaneous Ketamine for Treatment of Post-traumatic Acute Pain in the Emergency Department ( INVESCK )

Start date: April 15, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

Pain is the most common complaint for emergency department (ED) visit. Intranasal ketamine has been shown to provide rapid, well-tolerated, effective analgesia to emergency department (ED) patients with acute pain. few trials have studied ketamine infusion subcutaneously for pain management in trauma patients.

NCT ID: NCT05226221 Recruiting - Clinical trials for Gastrointestinal Cancer

Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality

GESEMM
Start date: September 1, 2021
Phase:
Study type: Observational

Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality

NCT ID: NCT05217706 Recruiting - Depression Clinical Trials

Low-Dose Intravenous Ketamine for Adolescents With Depression and Suicidal Ideation in the Emergency Department

Start date: March 1, 2022
Phase: Early Phase 1
Study type: Interventional

The goal of this study is to test whether a single low-dose of IV ketamine given in the emergency department to adolescents with treatment-resistant depression and suicidal ideation can reduce depression symptoms and suicidal thoughts compared to placebo. Participants will complete depression scales at baseline, and 1 hour, 3 hours, 1 day, 3 days, and 7 days after receiving the treatment.